Project Grant K23HL179489
- This federal Project Grant award, valued at $162,703.00 and granted by the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research), aims to determine whether streamlined, standardized blood pressure (BP) measurement protocols can be implemented in primary care settings. The project builds on the Alabama Cardiovascular Cooperative's Heart Health Improvement Project and seeks to improve the accuracy and efficiency of BP measurements to inform treatment decisions...
- This federal Project Grant award of $708,678, provided by the National Heart, Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research), aims to conduct a Sequential Multiple Assignment Randomized Trial (SMART) to reduce food insecurity and improve adherence in patients with hypertension. The key products and services to be delivered under this grant include: Determining the most effective initial food insecurity intervention (resource information or community health worker...
- This Project Grant award, totaling $169,444, was provided by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to develop and pilot test a stress management intervention for Black adults with hypertension. The project will work with patients receiving care from federally-qualified health centers to iteratively design an intervention that addresses patient preferences and aims to promote cardiovascular health. Key outcomes to be examined include...
- The University of Alabama at Birmingham (UAB) received a $222,750 Project Grant from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to develop a clinical decision support questionnaire to identify barriers to blood pressure control. The project aims to address the high rates of uncontrolled hypertension in the U.S., which is a leading cause of morbidity, mortality, and substantial healthcare costs. The award, with a performance period from July...
- The federal Project Grant award of $535,556.00 was provided by the National Heart Lung and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of Alabama at Birmingham (UAB). The funding will support a research project to investigate the role of a novel histone modification, H3T32 O-GlcNAc, in endothelial cell dysfunction and atherosclerosis. The 5-year project aims to elucidate the epigenetic features of this histone modification under...
- This Project Grant award of $142,870 from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports Emory University's investigation into the multi-level determinants of inequities in end-of-life care for adults with heart failure. The key objectives are to: Characterize the influence of individual and hospital-level factors on end-of-life heart failure care through hierarchical multiple regression analysis. Quantify the impact of neighborhood-based...
- This Project Grant award of $807,067.00 from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) will support a study to pioneer the quantitative documentation of human respiratory kinematic profiles. The study aims to address a critical gap in contemporary physiological monitoring - the inability to quantify labored breathing, which contains vital prognostic information not captured by conventional monitoring. Building on a recent innovation called ARK...
- This Project Grant award, valued at $498,991.40, was provided by the National Heart Lung and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of Arkansas, Fayetteville. The goal is to engineer microphysiological systems with tight oxygen control to investigate the molecular pathways activated in oxygen gradients and the resulting effects on cardiomyocyte function, in order to obtain a comprehensive understanding of the cardiac response to hypoxic...
- This $150,000 project grant from the National Science Foundation's Computer and Information Science and Engineering program aims to develop technologies to improve cardiac care for patients in rural and tribal areas of Arizona. Clemson University is partnering with Northern Arizona University and community leaders to plan an integrated remote heart monitoring system. The system will utilize deep learning and Markov-based methods to predict deterioration in symptoms for patients with conditions...
- The George Washington University received a $178,367 Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) for the "SUPPORT YOUR HEART: FEASIBILITY TRIAL OF A CARDIOVASCULAR HEALTH INTERVENTION FOR YOUNG ADULTS" project. This 2-year feasibility study aims to develop and evaluate a telephone-delivered health coaching intervention for young adults targeting the American Heart Association's "Life's Essential 8"...
This federal Project Grant award for $170,601, provided by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research), supports the development and pilot testing of a multi-component remote care intervention for rural patients living with heart failure. The project aims to: 1) elicit feedback on remote intervention strategies to inform implementation of heart failure care within rural communities; 2) conduct a pilot trial to examine the feasibility and acceptability of three intervention strategies (video-based visits, remote patient monitoring, and remote self-care education); and 3) characterize contextual factors relevant to the delivery and implementation of these remote care strategies. This research seeks to identify an optimal combination of intervention components to facilitate remote heart failure care for rural populations, who face significantly higher mortality from this condition compared to urban communities. The award is held by the University of Alabama at Birmingham and has an initial funding period from August 1, 2025 through July 31, 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $170.6k | 7/31/25 |